for the betterment of society, or for the enrichment of Big Pharma & all of those who have their hands in Pharm's deep pockets (academicians, so-called independent experts, the MSM)? So many instances where HCQ is being intentionally maligned in the research/clinical trial world...sad reality. Also, just because a study may be randomized/placebo-controlled/double-blinded doesn't make it valid, or even on point. You can tailor any study to your (Big Pharma's) desired outcome...like practically overdosing HCQ cohorts in already hospitalized/critically ill/high-risk patients (many with cardiac disease/failure). It's not too difficult to tarnish a drug if there's enough $ incentive.
One simply needs to keep his eye on legitimate studies that not only "properly dose", but also "properly test/utilize" HCQ as a "combination" drug (not monotherapy) in an "ambulatory" setting. "Early use" is key for any anti-viral in general...once you wait until someone is critically ill, oxygen-requiring, mechanically ventilated or in the ARD stage, the viral load is much too high & "any" anti-viral will show little to no benefit in terms of reducing mortality. Unfortunately, too few studies exist looking at HCQ properly.
https://healthimpactnews.com/2020/editors-of-the-lancet-and-the-new-england-journal-of-medicine-pharmaceutical-companies-are-so-financially-powerful-they-pressure-us-to-accept-papers/